You will learn to analyze the most frequent clinical signs of the most common viral diseases in small animals”

Vector-borne diseases, i.e., hematophagous arthropods, are a group of different entities produced by bacteria, viruses, protozoa and helminths. They are considered emerging (and sometimes non-emerging) in daily canine clinical practice. These diseases produce a great diversity of clinical pictures, they can be asymptomatic or can cause the death of the animal. Infectious diseases caused by parasites (Nematodes, Protozoa, Trematodes and Cestodes) are frequent in dogs, generally with gastrointestinal symptoms; the group of pulmonary parasites produces emerging pathologies in the patient. 

Enterobacteriaceae are another cause of gastrointestinal diseases in the dog that include zoonotic bacteria of potential risk to the patient. To a lesser degree, within the differential diagnoses, some species of algae also generate chronic conditions that affect the digestive system of dogs. Viral diseases in the feline species are often difficult for the small animal veterinarian to deal with. Some diseases present typical clinical signs, while others have different manifestations and present pictures similar to other pathologies or even neoplasms. 

Due to the particularities of the cat, there are certain differences in the approach with respect to the dog, such as specific bacteria of the feline species and typical bacterial and fungal clinical pictures. Among the parasites affecting the feline species, the clinic is always more familiar with those most frequently diagnosed and most prevalent. 

For all these reasons, the interest in this field has been increasing in recent years, which is why TECH offers this 100% online program, designed by experts in Small Animal Infectious Diseases, through only 12 months of specialization, 100% online and tailor-made by experts in Small Animal Infectious Diseases. Graduates are, therefore, guaranteed an academic experience that can be perfectly combined with any other work activity, which will allow them to update and perfect their professional skills in a guaranteed manner. 

An educational program based on the best working methods of the online educational panorama, revolutionary in the veterinary field”

 

This Master's Degree in Infectious Diseases in Small Animals contains the most complete and up-to-date scientific program on the market. Its most notable features are:  

• The latest technology in online teaching software
• A highly visual teaching system, supported by graphic and schematic contents that are easy to assimilate and understand
• Practical cases presented by practising experts
• State-of-the-art interactive video systems
• Teaching supported by telepractice
• Continuous updating and recycling systems
• Autonomous learning: full compatibility with other occupations
• Practical exercises for self-evaluation and learning verification
• Support groups and educational synergies: questions to the expert, debate and knowledge forums
• Communication with the teacher and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection
• Supplementary documentation databases are permanently available, even after the program

Each and every area of knowledge needed regarding Infectious Diseases in Small Animals, clearly, comprehensively and effectively presented”

Its teaching staff includes professionals belonging to the field of Veterinary Medicine, who bring to this educational program the experience of their work, as well as renowned specialists from reference societies and prestigious universities. 

Theultimerdia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive learning programmed to study in real situations. 

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced psychology experts.   

High-impact program that will give you the qualifications you need to act as an expert in this field of work"

Fully compatible with your daily life activities, it will allow you to learn in a constant and gradual way, at your own pace, without losing educational effectiveness"

This program has been designed with a specific teaching model that successfully combines the intensity of a comprehensive and complete study with a highly flexible way of learning. A knowledge journey that addresses each and every area of professional development that the veterinarian needs in the field of small animal infectious diseases. 

A unique teaching model that reconciles distance specialization with practical learning, allowing the professional to progress in their care capacity by studying with the best teaching program on the online market”

Module 1. Introduction and Laboratory Diagnosis

1.1. Prevalence and Epidemiology of Infectious Diseases in Small Animals

1.1.1. Introduction to the Epidemiology of Infectious Diseases
1.1.2. Epidemiological Characteristics of Infectious Diseases
1.1.3. Prevalence and Clinical Epidemiology

1.2. Diagnosis of Viral Diseases

1.2.1. The Role of Viruses in Veterinary Medicine
1.2.2. Viral Isolation
1.2.3. Antigen Detection Techniques by Immunological Techniques
1.2.4. Molecular Techniques (Polymerase Chain Reaction, PCR)

1.2.4.1. The Role of PCR Inhibitors

1.2.5. Histopathology
1.2.6. Serology Testing
1.2.7. Interpretation of Tests in Clinical Diagnosis

1.3. Diagnosis of Parasitic Diseases

1.3.1. The Role of Parasites in Veterinary Medicine
1.3.2. The Importance of the Coprological Analysis in the Daily Clinic

1.3.2.1. Coprological Techniques

1.3.3. Hematic Parasites, the Usefulness of Blood Smears
1.3.4. Serology in Parasitic Diseases

1.4. Diagnosis of Bacterial and Fungal Diseases

1.4.1. Direct Visualization Under the Microscope
1.4.2. Culture and Identification

1.4.2.1. Urine Culture and CFU
1.4.2.2. Anaerobic Bacteria
1.4.2.3. Interpretation of Antibiograms
1.4.2.4. Saprophyte, Opportunistic or Pathogenic

1.4.3. Molecular Techniques (Polymerase Chain Reaction, PCR)
1.4.4. Serology Testing
1.4.5. Histopathology

1.5. Procedures in Clinical Practice

1.5.1. Sampling for Bacterial Cultures
1.5.2. Sampling for Fungal Cultures
1.5.3. Blood Cultures
1.5.4. Anaerobic Cultures
1.5.5. Conservation of Microbiology Samples
1.5.6. Serum or Plasma? Hysop With or Without Medium?

1.6. Cytology Applied to Diagnosis. Skin

1.6.1. General Aspects
1.6.2. Techniques for Obtaining Samples
1.6.3. Staining Techniques
1.6.4. Principles of Cytological Interpretation

1.6.4.1. Interpretation of Cell Lines
1.6.4.2. Bacterial Diseases
1.6.4.3. Fungal Diseases
1.6.4.4. Parasitic Diseases

1.7. Cytology Applied to Diagnosis. Lymph Nodes

1.7.1. General Aspects
1.7.2. Techniques for Obtaining Samples
1.7.3. Staining Techniques
1.7.4. Principles of Cytological Interpretation

1.7.4.1. Interpretation of Cell Lines
1.7.4.2. Bacterial Diseases
1.7.4.3. Fungal Diseases
1.7.4.4. Parasitic Diseases

1.8. Cytology Applied to Diagnosis. Blood and Bone Marrow

1.8.1. General Aspects
1.8.2. Techniques for Obtaining Samples
1.8.3. Staining Techniques
1.8.4. Principles of Cytological Interpretation

1.8.4.1. Interpretation of Cell Lines
1.8.4.2. Bacterial Diseases
1.8.4.3. Fungal Diseases 
1.8.4.4. Parasitic Diseases
1.8.4.5. Viral Diseases

1.9. Cytology Applied to Diagnosis: Respiratory and Digestive System

1.9.1. General Aspects
1.9.2. Techniques for Obtaining Samples
1.9.3. Staining Techniques
1.9.4. Principles of Cytological Interpretation

1.9.4.1. Interpretation of Cell Lines
1.9.4.2. Bacterial Diseases
1.9.4.3. Fungal Diseases
1.9.4.4. Parasitic Diseases

1.10. Cytology Applied to Diagnosis. Sensory Organs

1.10.1. General Aspects
1.10.2. Techniques for Obtaining Samples
1.10.3. Staining Techniques
1.10.4. Principles of Cytological Interpretation

1.10.4.1. Interpretation of Cell Lines
1.10.4.2. Bacterial Diseases
1.10.4.3. Fungal Diseases
1.10.4.4. Parasitic Diseases

Module 2. Infectious Diseases in the Canine Species (I). Viral Diseases

2.1. Distemper

2.1.1. Etiological Agent
2.1.2. Epidemiology
2.1.3. Clinical Manifestations
2.1.4. Specific Diagnosis
2.1.5. Treatment

2.2. Parvovirus and Enteric Viruses

2.2.1. Etiological Agents Involved
2.2.2. Epidemiology
2.2.3. Pathogenesis
2.2.4. Clinical Manifestations and Lesions
2.2.5. Specific Diagnosis
2.2.6. Treatment

2.3. Canine Herpesvirus

2.3.1. Etiological Agent
2.3.2. Epidemiology
2.3.3. Pathogenesis
2.3.4. Clinical Manifestations and Lesions
2.3.5. Specific Diagnosis
2.3.6. Treatment

2.4. Kennel Cough

2.4.1. Etiological Agents Involved
2.4.2. Epidemiology
2.4.3. Pathogenesis
2.4.4. Clinical Manifestations and Lesions
2.4.5. Specific Diagnosis
2.4.6. Treatment

2.5. Canine Influenza and other Respiratory Viruses

2.5.1. Etiological Agents Involved
2.5.2. Epidemiology
2.5.3. Pathogenesis
2.5.4. Clinical Manifestations and Lesions
2.5.5. Specific Diagnosis
2.5.6. Treatment

2.6. Canine Infectious Hepatitis

2.6.1. Etiological Agent
2.6.2. Epidemiology
2.6.3. Pathogenesis
2.6.4. Clinical Manifestations and Lesions
2.6.5. Specific Diagnosis
2.6.6. Treatment

2.7. Viral Papillomatosis

2.7.1. Etiological Agent
2.7.2. Epidemiology
2.7.3. Pathogenesis
2.7.4. Clinical Manifestations and Lesions
2.7.5. Specific Diagnosis
2.7.6. Treatment

2.8. Rabies and Pseudorabies (Aujeszky's Disease)

2.8.1. Etiological Agents
2.8.2. Clinical Manifestations
2.8.3. Specific Diagnosis
2.8.4. Problem Situations
2.8.5. Preventive Strategies

2.9. Botulism

2.9.1. Etiological Agents
2.9.2. Epidemiology
2.9.3. Clinical Manifestations
2.9.4. Specific Diagnosis
2.9.5. Treatment 

2.10. Tetanus

2.10.1. Etiological Agent
2.10.2. Epidemiology
2.10.3. Clinical Manifestations
2.10.4. Specific Diagnosis
2.10.5. Treatment 

Module 3. Infectious Diseases in the Canine Species (II). Vector and Bacterial Diseases (I)

3.1. Ehrlichiosis

3.1.1. Epidemiology
3.1.2. Clinical Manifestations
3.1.3. Specific Diagnosis
3.1.4. Treatment

3.2. Piroplasmosis or Babesia

3.2.1. Etiology and Pathogenesis
3.2.2. Host and Transmission
3.2.3. Clinical Signs
3.2.4. Diagnosis and Treatment

3.3.  Anaplasmosis

3.3.1. Etiological Agents
3.3.2. Epidemiology
3.3.3. Clinical Manifestations
3.3.4. Specific Diagnosis
3.3.5. Treatment

3.4. Hemotropic Mycoplasma

3.4.1. Etiological Agents
3.4.2. Epidemiology
3.4.3. Clinical Manifestations
3.4.4. Specific Diagnosis
3.4.5. Treatment

3.5. Hepatozoonosis

3.5.1. Etiological Agents
3.5.2. Epidemiology
3.5.3. Clinical Manifestations
3.5.4. Specific Diagnosis
3.5.5. Treatment

3.6. Visceral Leishmaniasis

3.6.1. Etiology and Pathogenesis
3.6.2. Host and Transmission
3.6.3. Clinical Signs
3.6.4. Diagnosis and Treatment

3.7. Neospora and Toxoplasma

3.7.1. Etiological Agents
3.7.2. Epidemiology
3.7.3. Clinical Manifestations
3.7.4. Specific Diagnosis
3.7.5. Treatment

3.8. Brucellosis

3.8.1. Etiological Agents
3.8.2. Epidemiology
3.8.3. Clinical Manifestations
3.8.4. Specific Diagnosis
3.8.5. Treatment

3.9. Dirofilariasis

3.9.1. Etiological Agents
3.9.2. Epidemiology
3.9.3. Clinical Manifestations
3.9.4. Specific Diagnosis
3.9.5. Treatment

3.10. Bartonellosis and Borreliosis

3.10.1. Etiological Agents
3.10.2. Epidemiology
3.10.3. Clinical Manifestations
3.10.4. Specific Diagnosis
3.10.5. Treatment

Module 4. Infectious Diseases in the Canine Species (III) Bacterial (II), Parasitic and Fungal Diseases

4.1. Leptospirosis

4.1.1. Etiological Agents
4.1.2. Epidemiology
4.1.3. Clinical Manifestations
4.1.4. Specific Diagnosis
4.1.5. Treatment

4.2. Mycobacteriosis

4.2.1. Etiological Agents
4.2.2. Epidemiology
4.2.3. Clinical Manifestations
4.2.4. Specific Diagnosis
4.2.5. Treatment

4.3. Superficial Mycoses

4.3.1. Dermatophytosis

4.3.1.1. Etiological Agents
4.3.1.2. Epidemiology
4.3.1.3. Clinical Manifestations
4.3.1.4. Specific Diagnosis
4.3.1.5. Treatment

4.3.2. Malassezia Dermatitis

4.3.2.1. Etiological Agent
4.3.2.2. Epidemiology
4.3.2.3. Clinical Manifestations
4.3.2.4. Specific Diagnosis
4.3.2.5. Treatment

4.4. Deep Mycosis

4.4.1. Etiological Agents
4.4.2. Epidemiology
4.4.3. Clinical Manifestations
4.4.4. Specific Diagnosis
4.4.5. Treatment

4.5. Aspergillosis

4.5.1. Etiological Agents
4.5.2. Epidemiology
4.5.3. Clinical Manifestations
4.5.4. Specific Diagnosis
4.5.5. Treatment

4.6. Enterobacteriaceae

4.6.1. Etiological Agents
4.6.2. Epidemiology
4.6.3. Clinical Manifestations
4.6.4. Specific Diagnosis
4.6.5. Treatment

4.7. Pulmonary Parasitosis

4.7.1. Etiological Agents
4.7.2. Epidemiology
4.7.3. Clinical Manifestations
4.7.4. Specific Diagnosis
4.7.5. Treatment

4.8. Gastrointestinal Parasitosis I. Protozoa

4.8.1. Epidemiology
4.8.2. Clinical Manifestations
4.8.3. Specific Diagnosis
4.8.4. Treatment

4.9. Gastrointestinal Parasitosis II. Helminths

4.9.1. Epidemiology
4.9.2. Clinical Manifestations
4.9.3. Specific Diagnosis
4.9.4. Treatment

4.10. Protothecosis and Algal Diseases

4.10.1. Etiological Agents
4.10.2. Epidemiology
4.10.3. Clinical Manifestations
4.10.4. Specific Diagnosis
4.10.5. Treatment

Module 5. Infectious Diseases in the Feline Species (I). Viral

5.1. Feline Leukemia Virus (FeLV). Epidemiology and Etiology

5.1.1. Situation in Europe and Latin America
5.1.2. Etiopathogenesis and its Relation to Diagnosis
5.1.3. Clinical Manifestations

5.2. Feline Leukemia Virus. Clinical Manifestations and Treatments

5.2.1. Associated Pathologies
5.2.2. Current Treatments. Evidence and Experience

5.3. Feline Immunodeficiency Virus (FIV)

5.3.1. Etiopathogenesis
5.3.2. Clinical Signs
5.3.3. Diagnosis
5.3.4. Diseases Associated with FIV Infection
5.3.5. Current Treatments

5.4. Feline Coronavirus (FCoV) and Feline Infectious Peritonitis (FIP)

5.4.1. Feline Coronavirus. Epidemiology, Etiopathogenesis and Clinical Signs
5.4.2. Pathogenesis of Feline Infectious Peritonitis (FIP)
5.4.3. Clinical Presentations. Signs and Forms

5.5. Feline Infectious Peritonitis (FIP)

5.5.1. Diagnosis: Combining Clinical and Techniques
5.5.2. Supportive and Experimental Therapies

5.6. Feline Herpesvirus (FHV)

5.6.1. Epidemiology
5.6.2. Pathogenesis and its Relationship to Clinical Signs
5.6.3. Clinical and Laboratory Diagnosis
5.6.4. Supportive and Antiviral Treatments

5.7. Feline Calicivirus (FCV)

5.7.1. Epidemiology
5.7.2. Pathogenesis
5.7.3. Clinical Pictures Associated with FCV and Systemic Virulent Calicivirus (SV-CVF)
5.7.4. Laboratory Diagnosis
5.7.5. Treatment of FCV-Associated Conditions
5.7.6. Supportive Treatment of FCV-VS Infection

5.8. Feline Parvovirus (FPV)

5.8.1. Epidemiology
5.8.2. Etiopathogenesis and its Relationship to Clinical Signs
5.8.3. Laboratory Diagnosis
5.8.4. Supportive Treatment of Feline Panleukopenia

5.9. Rabies in Cats

5.9.1. Epidemiology. Current Situation in Europe and Latin America
5.9.2. Pathogenesis and Clinical Pictures
5.9.3. Laboratory Diagnosis
5.9.4. Treatment and Prevention

5.10. Other Viruses Affecting Cats

5.10.1. Feline Spumavirus
5.10.2. Papillomatosis
5.10.3. Cowpox
5.10.4. Morbillivirus
5.10.5. Pseudorabies
5.10.6. Avian Influenza (H3N2)
5.10.7. SARS-CoV-2

Module 6. Infectious Diseases in the Feline Species (II). Bacteria and Fungi

6.1. Bacteria Affecting the Respiratory and Ocular Systems (I)

6.1.1. Respiratory Mycoplasmas
6.1.2. Chlamydiosis
6.1.3. Bordetella Bronchiseptica

6.2 Bacteria Affecting the Respiratory and Ocular System (II)

6.2.1. Pasteurella
6.2.2. Pseudomonas
6.2.3. Klebsiella Pneumoniae
6.2.4. Escherichia coli
6.2.5. Actinomycosis and Nocardiosis

6.3. Bacteria Affecting the Digestive System

6.3.1. Bacteria Affecting the Gastrointestinal Tract

6.3.1.1. Campylobacteriosis
6.3.1.2. Salmonellosis
6.3.1.3. Chlostridiosis
6.3.1.4. Escherichia coli
6.3.1.5. Helicobacter

6.3.2. Bacterial Cholangitis and Bacterial Cholangiohepatitis

6.4. Cutaneous Bacteria

6.4.1. Streptococcus
6.4.2. Staphylococcus
6.4.3. Abscess-Forming Bacteria

6.4.3.1. Nocardiosis
6.4.3.2. Actinomycosis
6.4.3.3. Rhodococcus

6.4.4. Bacteria Involved in Bite Wounds

6.5. Bacteria Affecting the Nervous System

6.5.1. Clostridium Tetani
6.5.2. Clostridium botulinum
6.5.3. Escherichia coli

6.6. Bacteria Affecting Other Organs. Nephrourinary, Cardiovascular and Systemic System

6.6.1. Gram Positive Bacteria
6.6.2. Gram Negative Bacteria
6.6.3. Bartonellosis
6.6.4. Leptospirosis
6.6.5. Management of the Feline Patient with Sepsis

6.7. Hemotropic Mycoplasma

6.7.1. Etiopathogenesis
6.7.2. Epidemiology
6.7.3. Clinical Signs and Diagnosis
6.7.4. Treatment

6.8. Mycobacteriosis

6.8.1. Types of Infections

6.8.1.1. Tuberculosis
6.8.1.2. Mycobacterium Avium complex
6.8.1.3. Feline Leprosy

6.8.2. Diagnosis of Mycobacterial Infections
6.8.3. Treatment of Mycobacterial Infections

6.9. Cutaneous Mycoses

6.9.1. Dermatophytosis
6.9.2. Malassezia Dermatitis

6.10. Systemic and Respiratory Mycoses

6.10.1. Cryptococcosis
6.10.2. Blastomycosis
6.10.3. Aspergillosis and Penicilliosis
6.10.4. Histoplasmosis
6.10.5. Candidiasis
6.10.6. Other Mycosis 

Module 7. Infectious Diseases in the Feline Species (III). Parasitic and Vector-Borne Diseases

7.1. Cutaneous Parasites (I)

7.1.1. Epidemiology: Review of the Current Situation in Europe and Latin America
7.1.2. Fleas
7.1.3. Lice
7.1.4. Ticks

7.2. Cutaneous Parasites (II)

7.2.1. Mites

7.2.1.1. Cheyletiella
7.2.1.2. Trombicula
7.2.1.3. Demodectic Mange
7.2.1.4. Otodectic Mange
7.2.1.5. Notohedral Mange
7.2.1.6. Sarcoptic Mange

7.2.2. Helminths

7.2.2.1. Thelazia

7.3. Digestive Parasites (I). Trematodes and Cestodes

7.3.1. Trematodes
7.3.2. Cestodes

7.3.2.1. Dipylidium
7.3.2.2. Tapeworms
7.3.2.3. Echinococcus
7.3.2.4. Mesocestoides

7.4. Digestive Parasites (II). Helminths

7.4.1. Ancylostoma
7.4.2. Uncinaria
7.4.3. Trichostrongylus
7.4.4. Toxocara Cati
7.4.5. Toxocara Canis
7.4.6. Physaloptera

7.5. Digestive Parasites (III). Protozoa

7.5.1. Cryptosporidium
7.5.2. Isospora
7.5.3. Sarcocystis
7.5.4. Tritrichomonas
7.5.5. Giardia
7.5.6. Entamoeba

7.6. Respiratory Parasites

7.6.1. Aleurostrongylus Abstrusus
7.6.2. Oslerus
7.6.3. Toxocara Cati

7.7. Toxoplasmosis

7.7.1. Prevention
7.7.2. Etiopathogenesis
7.7.3. Clinical Signs
7.7.4. Clinical and Laboratory Diagnosis
7.7.5. Treatment

7.8. Vector-Borne Infectious Diseases I

7.8.1. Bartonellosis
7.8.2. Ehrlichiosis
7.8.3. Anaplasmosis
7.8.4. Borreliosis
7.8.5. Coxiellosis

7.9. Vector-Borne Infectious Diseases II

7.9.1. Babesiosis
7.9.2. Cytauxzoonosis
7.9.3. Hepatozoonosis

7.10.  Vector-Borne Infectious Diseases III

7.10.1. Leishmaniasis
7.10.2. Dirofilariasis

Module 8. Tropical Diseases

8.1. Canine Leishmaniasis: A View from Latin America

8.1.1. Canine Tegumentary Leishmaniasis in Latin America
8.1.2. Canine Visceral Leishmaniasis in Latin America
8.1.3. Control and Prevention Measures

8.2. Canine Trypanosomiasis

8.2.1. Etiological Agents 
8.2.2. Epidemiology
8.2.3. Clinical Manifestations
8.2.4. Specific Diagnosis
8.2.5. Treatment

8.3. Rangeliosis and Other Pyroplasmas

8.3.1. Etiological Agents
8.3.2. Epidemiology
8.3.3. Clinical Manifestations
8.3.4. Specific Diagnosis
8.3.5. Treatment

8.4. Gurltia Paralysans and Lagochilascaris Spp

8.4.1. Etiological Agents
8.4.2. Epidemiology
8.4.3. Clinical Manifestations
8.4.4. Specific Diagnosis
8.4.5. Treatment

8.5. Feline Sporotrichosis

8.5.1. Etiological Agents
8.5.2. Epidemiology
8.5.3. Clinical Manifestations
8.5.4. Specific Diagnosis
8.5.5. Treatment

8.6. Rhinosporidiosis

8.6.1. Etiological Agents
8.6.2. Epidemiology
8.6.3. Clinical Manifestations
8.6.4. Specific Diagnosis
8.6.5. Treatment

8.7. Dioctophimosis

8.7.1. Etiological Agents
8.7.2. Epidemiology
8.7.3. Clinical Manifestations
8.7.4. Specific Diagnosis
8.7.5. Treatment

8.8. Trematodes in Canines and Felines

8.8.1. Etiological Agents
8.8.2. Epidemiology
8.8.3. Clinical Manifestations
8.8.4. Specific Diagnosis
8.8.5. Treatment

8.9. Rabies in the Americas 

8.9.1. Background
8.9.2. Epidemiology and Current Situation
8.9.3. Diagnosis, Surveillance and Control

8.10. Leptospirosis in the Americas

8.10.1. Background
8.10.2. Epidemiology and Current Situation
8.10.3. Diagnosis, Surveillance and Control

Module 9. Zoonotic

9.1. Past, Present and Future of Zoonoses

9.1.1. What are Zoonoses?
9.1.2. Types of Zoonoses
9.1.3. Historical Importance
9.1.4. The Role of the Small Animal Veterinarian

9.2. Zoonotic Risk Analysis. Vision One Health

9.2.1. Animal Health Risk Analysis
9.2.2. Risk Analysis Terminology
9.2.3. Stages of the Analysis
9.2.4. Perspectives and Limitations

9.3. Bacterial I. Campylobacteriosis, Salmonellosis and Chlostridiosis

9.3.1. Campylobacteriosis and salmonellosis
9.3.2. Chlostridiosis
9.3.3. Risk Factors
9.3.4. Prevention and Control

9.4. Bacterial II. Brucellosis, Leptospirosis and Bartonellosis

9.4.1. Brucellosis
9.4.2. Leptospirosis
9.4.3. Bartonellosis
9.4.4. Prevention and Control

9.5. Protozoa (I). Giardiasis and Toxoplasmosis

9.5.1. Giardiasis
9.5.2. Toxoplasmosis
9.5.3. Risk Factors
9.5.4. Prevention and Control

9.6. Protozoa (II). Leishmaniasis and Cryptosporidiosis

9.6.1. Leishmaniasis
9.6.2. Cryptosporidiosis
9.6.3. Risk Factors
9.6.4. Prevention and Control

9.7. Nematodes and Cestodes. Toxocara, Dipylidium and Echinococcus

9.7.1. Toxocara
9.7.2. Dipylidium
9.7.3. Echinococcus
9.7.4. Prevention and Control

9.8. Viral. Rabies

9.8.1. Epidemiology
9.8.2. Clinical Picture in Humans
9.8.3. Prophylactic and Control Measures

9.9. Mange and Dermatomycosis

9.9.1. Mange
9.9.2. Dermatomycosis
9.9.3. Prophylaxis and Control

9.10. Antimicrobial Resistance (ARM). Global Risk

9.10.1. Importance of Antimicrobial Resistance
9.10.2. Acquired Mechanisms of Antimicrobial Resistance
9.10.3. Global Strategies for the Reduction of Antimicrobial Resistance

Module 10. Vaccination and prevention

10.1. Vaccination in Dogs I

10.1.1. Types of Vaccines
10.1.2. Canine Vaccination Protocol. Primovaccination and Revaccination
10.1.3. Vaccination Under Special Conditions
10.1.4. Action Protocol
10.1.5. Vaccine Reactions
10.1.6. Immunization Failures. Factors Involved

10.2. Vaccination in Dogs II

10.2.1. Essential Vaccines
10.2.2. Complementary Vaccines
10.2.3. Non-Recommended Vaccines

10.3. Vaccination in Cats I

10.3.1. Feline Vaccination Protocol
10.3.2. Vaccination Under Special Conditions
10.3.3. Action Protocol
10.3.4. Vaccine Reactions. Expected and Undesirable
10.3.5. Immunization Failures. Factors Involved

10.4. Vaccination in Cats II

10.4.1. Essential Vaccines
10.4.2. Complementary Vaccines
10.4.3. Non-Recommended Vaccines

10.5. Preventive Management of Vector-Borne Diseases

10.5.1. Importance of Vector-Borne Disease Management
10.5.2. Factors Involved
10.5.3. Classification of Vector-Borne Diseases According to the Type of Vector Responsible for Vectors

10.6. Preventive Management of External and Internal Parasitosis in Dogs

10.6.1. Importance of Parasitosis Prevention
10.6.2. Factors Involved
10.6.3. Classification of Parasitic Diseases According to the Agent

10.6.3.1. Ectoparasites
10.6.3.2. Endoparasites

10.6.4. Relevance of Combination Therapy

10.7. Preventive Management of External and Internal Parasitosis in the Cat

10.7.1. Importance of Parasitosis Prevention
10.7.2. Factors Involved
10.7.3.  Classification of Parasitic Diseases According to the Agent

10.7.3.1. Ectoparasites
10.7.3.2. Endoparasites

10.7.4. Relevance of Combination Therapy

10.8. Sanitary Management of Kennels

10.8.1. Characteristics of the Facilities
10.8.2. Cleaning. Order and Products to be Used
10.8.3. Vaccination Programs
10.8.4. Deworming Programs
10.8.5. Sanitary Vacuum. Why, When and How to Perform it

10.9. Sanitary Management of Cat Catteries

10.9.1. Characteristics of the Facilities
10.9.2. Cleaning. Order and Products to be Used
10.9.3. Vaccination Programs
10.9.4. Deworming Programs
10.9.5. Sanitary Vacuum: Why, When and How to Perform it

10.10. Disaster Management

10.10.1. Main Types of Disasters

10.10.1.1. Meteorological Disasters
10.10.1.2. Natural Disasters
10.10.1.3. Biological Disasters Pandemics

10.10.2. Preventive Measures

10.10.2.1. Census of Animals
10.10.2.2. Preparation and Organization of Facilities to be Used as Shelter
10.10.2.3. Personnel and Means of Transport
10.10.2.4. Current Legislation in Force in Cases of Catastrophes in Relation to Companion Animals

It advances towards excellence with the help of the best professionals and teaching resources of the moment”